mRNA COVID-19 Vaccines Do Not Increase Short-Term Risk of Relapse in MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis
J. Neurol. Neurosurg. Psychiatr. 2021 Aug 18;[EPub Ahead of Print], M Di Filippo, C Cordioli, S Malucchi, P Annovazzi, P Cavalla, V Torri Clerici, P Ragonese, V Nociti, M Radaelli, A Laroni, F Buttari, L Lorefice, D Ferraro, A Gajofatto, L Prosperini, R Fantozzi, L Boffa, R Lanzillo, M Moccia, M Clerico, G De Luca, V Tomassini, M Calabrese, A Borrelli, D Paolicelli, GT Maniscalco, P Gazzola, A Gallo, C Solaro, E Cocco, C Gasperini, C TortorellaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.